TNFRSF10A and cancer: While an initial study showed that the chemotherapeutic agent doxorubicin and etoposide induce DR5 [19], subsequent studies have shown that several agents can induce the expression of DR4 and DR5, which can sensitize cancer cells to chemotherapy and radiation therapy [6].